Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Revolution Medicines, Inc.
Institut du Cancer de Montpellier - Val d'Aurelle
Verastem, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Intima Bioscience, Inc.
DualityBio Inc.
Lumicell, Inc.
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
DualityBio Inc.
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
BicycleTx Limited
Revolution Medicines, Inc.
National Institutes of Health Clinical Center (CC)
National University Hospital, Singapore
Bolt Biotherapeutics, Inc.
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Thomas Jefferson University
Imugene Limited